, Tracking Stock Market Picks
Enter Symbol:

down 61.35 %

NEURALSTEM INC (CUR) rated Buy with price target $8 by Brean Capital

Posted on: Wednesday,  Feb 18, 2015  8:25 AM ET by Brean Capital

Brean Capital rated Buy NEURALSTEM INC (NASDAQ: CUR) on 02/18/2015, when the stock price was $3.83. Since
then, NEURALSTEM INC has lost 61.36% as of 01/14/2016's recent price of $1.48.
If you would have followed this Brean Capital's recommendation on CUR, you would have lost 61.35% of your investment in 330 days.

Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine. The Company manufactures its cells both in-house and on an outsource basis. It uses these cells in its research grant and collaborative programs. The Company outsources all the manufacturing and storage of its stem cells to be used in pre-clinical works to Charles River Laboratories, Inc., of Wilmington, Massachusetts. The Charles River facility has the capacity to be used for cell processing under the United States Food and Drug Administration (FDA) determined good manufacturing practices (GMP) in quantities sufficient for its current pre-trial and anticipated future clinical trial needs. As of December 31, 2008, the Company had not identified any specific product.

Brean Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/18/2015 8:25 AM Buy
3.83 8.00
as of 8/27/2015
1 Week up  8.82 %
1 Month down  -30.18 %
3 Months down  -14.94 %
1 YTD down  -61.35 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy